Genzel Yvonne, Vogel Thomas, Buck Johannes, Behrendt Ilona, Ramirez Daniel Vazquez, Schiedner Gudrun, Jordan Ingo, Reichl Udo
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg Sandtorstr. 1, 39106 Magdeburg, Germany.
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg Sandtorstr. 1, 39106 Magdeburg, Germany; University of Applied Sciences Esslingen, Kanalstrasse 33, 73728 Esslingen, Germany.
Vaccine. 2014 May 19;32(24):2770-81. doi: 10.1016/j.vaccine.2014.02.016. Epub 2014 Feb 25.
High cell densities in animal cell culture can be obtained by continuous perfusion of fresh culture medium across hollow fiber membranes that retain the cells. Careful selection of the membrane type and cut-off allows to control accumulation of target molecules and removal of low molecular weight compounds. In this report, perfusion with the scalable ATF (alternating tangential filtration, Refine Technology) system was evaluated for two suspension cell lines, the avian cell line AGE1.CR and the human cell line CAP. Both were cultivated in chemically defined media optimized for batch cell growth in a 1L stirred tank bioreactor connected to the smallest ATF unit (ATF2) and infected with cell line-adapted human influenza A virus (A/PR/8/34 (H1N1), typical diameter: 80-100 nm). At concentrations of about 25 million cells/mL three different membrane cut-offs (50 kDa, 0.2 μm and 0.5 μm) were tested and compared to batch cultivations performed at 5 million cells/mL. For medium and large cut-offs no cell-density effect could be observed with cell-specific virus yields of 1428-1708 virions/AGE1.CR cell (infected with moi 0.001) and 1883-4086 virions/CAP cell (moi of 0.025) compared to 1292 virions/AGE1.CR cell and 3883 virions/CAP cell in batch cultures. Even at a concentration of 48 million AGE1.CR cells/mL (cut-off: 0.2 μm) a cell-specific yield of 1266 virions/cell was reached. Only for the small cut-off (50 kDa) used with AGE1.CR cells a decrease in cell-specific yield was measured with 518 virions/cell. Surprisingly, the ratio of infectious to total virions seemed to be increased in ATF compared to batch cultures. AGE1.CR cell-derived virus particles were present in the permeate (0.2 and 0.5 μm cut-off), whereas CAP cell-derived virions were not, suggesting possible differences in morphology, aggregation or membrane properties of the virions released by the two cell lines. To our knowledge, this is the first study that illustrates the potential of ATF-based perfusion of chemically defined media across cell-retaining membranes for production of an influenza A vaccine.
通过将新鲜培养基持续灌注通过能截留细胞的中空纤维膜,可以在动物细胞培养中获得高细胞密度。仔细选择膜的类型和截留分子量,能够控制目标分子的积累以及去除低分子量化合物。在本报告中,对两种悬浮细胞系——禽细胞系AGE1.CR和人细胞系CAP,评估了使用可扩展的交替切向流过滤(ATF,Refine Technology公司)系统进行灌注培养的效果。这两种细胞系均在经化学限定、优化用于分批细胞生长的培养基中培养,培养过程在连接到最小ATF单元(ATF2)的1L搅拌罐生物反应器中进行,并接种适应细胞系的甲型流感病毒(A/PR/8/34 (H1N1),典型直径:80 - 100 nm)。在细胞浓度约为2500万个/mL时,测试了三种不同的膜截留分子量(50 kDa、0.2μm和0.5μm),并与在500万个/mL细胞浓度下进行的分批培养作比较。对于中等和大截留分子量的情况,未观察到细胞密度效应,与分批培养相比,细胞特异性病毒产量分别为1428 - 1708个病毒粒子/AGE1.CR细胞(感染复数为0.001)和1883 - 4086个病毒粒子/CAP细胞(感染复数为0.025),而分批培养中分别为1292个病毒粒子/AGE1.CR细胞和3883个病毒粒子/CAP细胞。即使在细胞浓度为4800万个/ mL AGE1.CR细胞(截留分子量:0.2μm)时,细胞特异性产量也达到了1266个病毒粒子/细胞。仅对于AGE1.CR细胞使用的小截留分子量(50 kDa),细胞特异性产量有所下降,为518个病毒粒子/细胞。令人惊讶的是,与分批培养相比,ATF培养中感染性病毒粒子与总病毒粒子的比例似乎有所增加。AGE1.CR细胞衍生的病毒粒子存在于渗透液中(截留分子量为0.2和0.5μm),而CAP细胞衍生的病毒粒子则不存在,这表明两种细胞系释放的病毒粒子在形态、聚集或膜性质方面可能存在差异。据我们所知,这是第一项说明基于ATF将化学限定培养基灌注通过细胞截留膜来生产甲型流感疫苗潜力的研究。